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MEMPHYS-Center for Biomembrane Physics, University of Southern Denmark, Odense, DenmarkABSTRACT Surfactant protein C (SP-C) is a hydrophobic lipopeptide that is critical for lung function, in part because it
physically catalyzes the formation of surface-associated surfactant reservoirs. Many of SP-C’s key biophysical properties derive
from its highly stable and hydrophobic a-helix. However, SP-C’s posttranslational modification with N-terminal palmitoyl chains
also seems to be quite important. We created a new (to our knowledge) class of variants of a synthetic, biomimetic family of
peptide mimics (peptoids) that allow us to study the functional effects of biomimetic N-terminal alkylation in vitro. Mimics
were designed to emulate the amphipathic patterning, helicity, and hydrophobicity of SP-C, and to include no, one, or two vicinal
amide-linked, N-terminal octadecyl chains (providing a reach equivalent to that of natural palmitoyl chains). Pulsating bubble
surfactometry and Langmuir-Wilhelmy surface balance studies showed that alkylation improved biomimetic surface activities,
yielding lower film compressibility and lower maximum dynamic surface tensions. Atomic force microscopy studies indicated
that alkyl chains bind to and retain segregated interfacial surfactant phases at low surface tensions by inducing 3D structural
transitions in the monolayer’s fluid-like phase, forming surfactant-associated reservoirs. Peptoid-based SP-C mimics are easily
produced and purified, and offer much higher chemical and secondary structure stability than polypeptide-based mimics. In
surfactant replacements intended for medical use, synthetic SP mimics reduce the odds of pathogen contamination, which
may facilitate the wider use of surfactant treatment of respiratory disorders and diseases.INTRODUCTIONLung surfactant (LS) is a complex lipid/protein material that
reduces and controls alveolar surface tension (g, mN/m)
during respiration. This reduces the work of breathing and
maintains alveolar patency, enabling normal respiration.
Phospholipids (PLs) make up 80% of LS’s biomass, and
neutral lipids and surfactant proteins (SPs) each account
for 10% (1). No single component is fully responsible for
LS’s emergent biophysical properties; rather, each species
contributes to surface activity. Saturated PLs are responsible
for LS’s g-reduction properties; however, these species are
poor single-component LSs that adsorb slowly to the air/
liquid (a/l) interface and fail to respread upon inhalation.
The addition of unsaturated PLs and neutral lipids improves
these properties to some extent. Although the hydrophobic
SPs, SP-B and SP-C, are minor components of LS (2%
(wt)), they improve surfactant adsorption and recycling of
the lipid film during respiration, and are required for surface
activity (2,3). SP-B and SP-C are critical constituents of
animal-derived, exogenous surfactant preparations used
for the treatment of infant respiratory distress syndrome,
which occurs in premature infants who lack functional LS.
SP-C is the smaller of the two hydrophobic SPs, at just 35
residues (Table 1). The mature lipopeptide contains a high
number of Val, Leu, and Ile, as well as an N-terminal palmi-
toylation motif, making SP-C exceedingly hydrophobic.Submitted August 17, 2010, and accepted for publication April 18, 2011.
*Correspondence: aebarron@stanford.edu or joberse@memphys.sdu.dk
Editor: Ka Yee C. Lee.
 2011 by the Biophysical Society
0006-3495/11/09/1076/10 $2.00SP-C’s secondary structure is simple and dominated by a
large, 37-A˚-long helical region (residues 9–34) (4). In an
interfacial lipid system, SP-C reorients to maximize interac-
tions between its poly-Val helix and the film’s lipid acyl
chains (5). SP-C’s strong lipid association is further
enhanced by two cationic residues as well as two palmitoy-
lated cysteine residues (positions 5 and 6) that promote elec-
trostatic and hydrophobic associations, respectively, with
anionic PLs (6).
Although it is a minor LS constituent, SP-C exerts
dramatic effects on surface activity (7). SP-C in PL suspen-
sions accelerates PL adsorption and transfer from the sub-
phase to the air-liquid (a/l) interface, rapidly forming
a surfactant layer (8). SP-C promotes binding of dispersed
lipid vesicles to newly formed surfactant layers, and upon
compression to high surface pressures (P, mN/m), catalyzes
the formation of stacked multilayers of excluded surfactant
material (9–11). SP-C’s interaction with these surfactant
structures retains fluid-phase PLs at the interface, improving
surfactant respreading and lowering the maximum g (gmax)
during respiration.
Although SP-C’s distinct molecular features facilitate PL
interactions and promote biophysical functioning, they
complicate its handling and that of synthetic peptide-based
analogs (12). SP-C’s high b-branched amino acid content
creates a marginally stable helix when isolated from natural
milieu, and yields a high propensity for inactivation via
b-strand aggregation and amyloid-like fibril formation
(13). Therefore, it is difficult to isolate native SP-C anddoi: 10.1016/j.bpj.2011.04.055
TABLE 1 SP-C and peptoid sequences
Alkylated Peptoid Analogues of SP-C 1077perform analog synthesis for the purpose of emulating or
probing SP-C’s mechanism (12).
A biomimetic approach that overcomes the difficulties
associated with SP-C and peptide variants is to use poly-
N-substituted glycines, or peptoids, as SP-C mimics (14,15).
Peptoids share a common backbone structure with peptides;
however, their side chains are displaced to the amide nitro-
gens (16). This renders peptoids invulnerable to proteases,
thus enhancing their bioavailability. When substituted with
chiral, bulky side chains, peptoids can adopt stable, polypro-
line-like helices that are stabilized by steric and, in some
instances, electronic repulsions between aromatic side
chains and carbonyl groups (17,18). Because peptoid helices
are conformationally stable but lack backbone hydrogen
bonding, they are ultrastable and do not aggregate over
time (19). Peptoids are relatively easy and cost-effective
to synthesize, with coupling efficiencies comparable to
those of peptide synthesis. Therefore, peptoids are prom-
ising candidates for protein mimicry that requires helicity
for function (14).
Here we expand on peptoid-based mimicry of SP-C by
focusing on the N-terminal region. Although the hydro-
phobic helix contributes to many of SP-C’s biophysical
properties, evidence suggests that the N-terminal segmentis responsible for important surface-active properties
(6,20). To investigate the functional roles of palmitoyl-like
modifications in peptoids, we created a series of nonalky-
lated and alkylated peptoids and characterized their
in vitro surface properties in a synthetic PL formulation.
Pulsating bubble surfactometry (PBS) and Langmuir-Wil-
helmy surface balance (LWSB) measurements show that
alkylation improves surface activity, resulting in reduced
film compressibility and improved dynamic respreading as
indicated by lower gmax. Atomic force microscopy (AFM)
results suggest that the alkyl chains retain interfacial surfac-
tant material at low g by inducing two- to three-dimensional
(2-3D) structural transitions in the monolayer’s fluid-like
phase. Therefore, SP-C-like N-terminal alkyl chains are
able to assist the formation of surfactant reservoirs that
facilitate respreading and reduce gmax during dynamic
cycling, consistent with behavior observed for native SP-C.MATERIALS AND METHODS
Materials
Peptoid synthesis reagents, primary amines, and palmitic acid (PA) were
obtained from Sigma-Aldrich (Milwaukee, WI). Fmoc-protected prolineBiophysical Journal 101(5) 1076–1085
1078 Brown et al.and Rink amide resin were obtained from NovaBiochem (San Diego, CA).
The organic solvents used were high-performance liquid chromatography
(HPLC) grade or better (Fisher Scientific, Pittsburgh, PA). DPPC and
POPG were obtained from Avanti Polar Lipids (Alabaster, AL). Texas-
Red 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylam-
monium salt (TR-DHPE) was acquired from Molecular Probes (Eugene,
OR). The SP-C (a gift from Jesu´s Pe´rez-Gil) was extracted from porcine
LS (21).Peptoid synthesis
Peptoid-based SP-C mimics (Table 1) were synthesized (433A ABI synthe-
sizer; Applied Biosystems, Foster City, CA) on solid phase according to the
submonomer method (16). Crude products were purified by reversed-phase
(RP)-HPLC (Waters) with a C4 column (Vydac) on a linear gradient of
40–90% solvent B in solvent A over 80 min (solvent A ¼ 0.1% TFA in
water, and solvent B ¼ 0.1% TFA in isopropanol). Peptoid purities were
confirmed at >97% by analytical RP-HPLC, and molar masses were
confirmed by electrospray ionization mass spectrometry.Pulsating bubble surfactometry
Static and dynamic characterization of film properties was performed on
a modified pulsating bubble surfactometer (General Transco, Largo, FL)
as previously described (22). The synthetic lipids (DPPC/POPG/PA,
68:22:9, by weight) were dissolved in chloroform/methanol (3:1 (v:v))
alone or with 2 mol % SP-C additive. Samples were dried and resuspended
in aqueous buffer (150 mM NaCl, 5 mM CaCl2, and 10 mM HEPES, pH
6.9) to a lipid concentration of 1 mg/mL. Samples were loaded onto the
surfactometer at 37C, a bubble (radius ¼ 0.4 mm) was formed, and an
image acquisition system used to determine bubble size and trans-film
pressure. For static adsorption, g versus time was recorded for 20 min.
We then collected dynamic measurements of g versus bubble surface
area by cycling the bubble radius (0.4–0.55 mm, oscillation frequency of
20 cycles/min, 10 min). Static and dynamic PBS experiments were
repeated a minimum of six times for each preparation. During dynamic
cycling, the image analysis system sometimes failed to fit the bubble at
low-g due to shape deformation, causing an apparent break in the PBS
loop. However, the pressure drop across the bubble was low in these
instances, and the amount of deformation observed was significant, con-
firming that g was <1 mN/m during breaks in the compression-expansion
loops (22).Langmuir-Wilhelmy surface balance studies
and fluorescence microscopy
We obtained surface pressure (P)-molecular area (A) isotherms using an
LWSB (trough area 240 cm2) as described previously (15). For each exper-
iment, a buffered subphase (150 mM NaCl, 5 mM CaCl2, and 10 mM
HEPES at pH 6.9) was heated to 25C or 37C, and a Wilhelmy surface
balance (Reigler & Kirstein, Berlin, Germany) was calibrated to monitor
P versus A. The surfactant sample in organic solution was spread at the
interface via a syringe, and after solvent evaporation was completed
(10 min), two Teflon barriers were compressed (22 A˚2/molecule/min).
Each film underwent three compression-expansion cycles to onset of
collapse and then expansion to high A. All LWSB experiments were repro-
ducibly repeated at least six times.
A compact microscope stand (MM40; Nikon, Tokyo, Japan) with a
100 W mercury lamp was used to obtain fluorescence microscopy (FM)
images on LWSB films. Fluorescence was detected by a Dage-MTI three-
chip color camera (Dage-MTI, Michigan City, IN) in conjunction with
a generation II intensifier (Fryer, Huntley, IL). Samples were spiked with
0.5 mol % of a fluorescently labeled lipid (TR-DHPE) for detection. Inclu-Biophysical Journal 101(5) 1076–1085sion of the labeled lipid at this concentration did not alter the film
morphology (23). FM experiments were performed on the same aqueous
buffer subphase at 37C with a barrier speed of 5 mm/min. Lipid domain
coverage and sizes were calculated with the use of ImageJ (24).AFM
We performed AFM imaging of interfacial monolayers using Langmuir-
Blodgett (LB) technology, which involves the transfer of interfacial mate-
rial to a solid support (25). We prepared supported surfactant monolayers
by initially spreading surfactant material onto buffered subphase (5 mM
Tris and 150 mM NaCl, pH 7.0) at 22C in an LB trough (NIMA Tech-
nology, Coventry, UK) to a P of ~1 mN/m. After 10 min, the film was
compressed (50 cm2/min) to the desired P and held for 5 min (for
isotherms, see Fig. S1 in the Supporting Material). A previously immersed,
freshly cleaved muscovite mica substrate (Plano, Wetzlar, Germany) was
then lifted at constant speed (10 mm/min) to deposit the surface layer
onto the mica substrate. The deposited LB films were dried overnight,
and topographical images were taken at three locations per P using an
atomic force microscope (JPK NanoWizard, JPK Instruments, Berlin,
Germany) in air tapping mode with silicon-SPM cantilevers (nanosensors;
NanoWorld AG, Neuchaˆtel, Switzerland).Statistical analysis
A one-way analysis of variance with post hoc Tukey-Kramer multiple
comparison testing was used for analysis of results (p < 0.05).RESULTS
Peptoid design and rationale
Efforts to develop a functional peptoid-based SP-C mimic
have incorporated SP-C’s important molecular and struc-
tural features, including its extreme hydrophobicity, overall
positioning of polar residues, and rigid helix (14). Detailed
structure-function studies with these mimics focused on
optimizing the helix length and side-chain chemistry (15),
and revealed that a helix length of 28 A˚, in similarity to
SP-C’s Val-rich region, gave rise to favorable surface
activity. In addition, it was discovered that preserving the
rigid nature of the helix was best accomplished with the
use of bulky aromatic rather than aliphatic side chains,
despite the aliphatic nature of SP-C’s helix.
Recent studies with peptide-based SP-C constructs
showed that the N-terminal region, including the thioester-
linked palmitoyl chains, plays an important biophysical
role in SP-C-related surfactant homeostasis (20,26). To
investigate the analogous role of alkyl chains in a peptoid,
we incorporated octadecylamine (Nocd) at the N-terminus
of our mimics. Nocd is a C18 primary alkyl amine that
approximates the length and hydrophobicity of a palmitoyl
chain, including the thioester bond. The alkyl chain was
selectively introduced on-resin during synthesis (the amide
linkage is stable against hydrolysis under alkaline condi-
tions, eliminating the need for purification steps postalkyla-
tion and minimizing exposure to harsh reaction conditions).
We created three analogs, termed peptoids 1, 2, and 3, which
Alkylated Peptoid Analogues of SP-C 1079had no, one, or two Nocd residues at the N-terminus, respec-
tively (Table 1). These analogs mimic SP-C residues 5–32
by having 14 a-chiral, aromatic residues in the helix along
with an achiral N-terminal stretch that grossly mimics the
human SP-C sequence. The free-solution SP-C mimics
were similarly helical by circular dichroism (CD)
(Fig. S2), with aromatic peptoid helix spectra that resembled
those of well-defined polyproline type I-like helices at 3
residues/turn and a 6 A˚ pitch (15). Independently of the
alkyl chains, the designed mimics replicate SP-C’s hydro-
phobicity, amphipathicity, and helicity.PBS
An essential biophysical property of LS is its ability to
rapidly adsorb from the alveolar subphase to the a/l inter-
face, forming a surface-active layer that regulates g during
respiration. PLs exhibit poor adsorption kinetics; however,
the inclusion of hydrophobic SPs yields surfactants that
reach an equilibrium g (geq) of 25 mN/m in <1 min
(8,27). The lipid mixture adsorption kinetics with and
without the addition of 2 mol % SP-C or SP-C mimics
were characterized on a modified PBS in static mode
(Fig. S3). The peptoid-enhanced formulations improved
the surfactant adsorption rate to geq-values of 30–32 mN/m,
though less than the natural porcine SP-C formulation. The
presence of one or two alkyl chains in the peptoid at this
concentration did not affect the already favorable surfactant
adsorption behavior.
LS is remarkably able to minimize pressure inequalities
and maintain patency among the alveoli, resulting in near-
zero g during respiratory expiration and rapid respreading
on inspiration, the latter reducing gmax. To assess the ability
of peptoid-based formulations to reduce and control g as
a function of surface area at physiological rates, we per-
formed dynamic PBS experiments at 37C with an oscilla-
tion frequency of 20 cycles/min and 50% reduction in
surface area. Important features for a biomimetic surfactant
in compression-expansion loops include a low minimum g
(gmin) with minimal compression (low compressibility),
and a low gmax indicating rapid respreading upon expansion
(28). PBS parameters (Table 2) and representative PBSTABLE 2 Dynamic PBS results
Formulation
1 min 5 m
gmax gmin* gmax
Lipids 65.45 3.4 12.95 4.0 64.25 2.8
Lipids þ SP-C 37.05 2.4 < 1 36.35 2.2
Lipids þ peptoid 1 50.85 2.2 < 1 51.15 1.3
Lipids þ peptoid 2 46.15 3.5 < 1 45.15 2.8
Lipids þ peptoid 3 46.35 3.2 < 1 45.55 2.2
Data are mean g5 SD in mN/m. For gmax and % compression, all groups were s
pC and Lipids þ Mimic di-pC at each time interval. For gmin, all SP-C and SP-C
*All experimental runs reached a gmin < 1 mN/m except for formulations com
yCompression refers to the percent relative compression necessary to reach a gcompression-expansion loops after 5 min of cycling are pre-
sented in Fig. 1 A. For the gmax and % compression values
shown in Table 2, all formulations were similar to each other
but different from the lipid formulation alone.
The lipid mixture exhibited a high gmax and gmin of
64 mN/m and 12 mN/m, respectively (Fig. 1 A and Table 2).
In addition, the film surface area compression tog< 20mN/m
was 45%. Adding SP-C to the lipid mixture improved the
surface activity of the film, as indicated by the lower gmax
of 36 mN/m and a gmin of <1 mN/m. The presence of
SP-C also decreased the compressibility of the surfactant,
with 8% compression to reach g< 20 mN/m. These features
were similar to those of Infasurf, a clinical surfactant replace-
ment therapy that contains both SP-B and SP-C (22).
The addition of peptoid to the lipids improved dynamic
film behavior in a manner similar to that observed for SP-C
(Fig. 1A and Table 2). Addition of peptoid 1 to lipids reduced
both gmax and gmin to 51 mN/m and<1 mN/m, respectively.
Inclusion of peptoid 1 also reduced the amount of compres-
sion necessary to reach ag< 20mN/m to 30%. The improve-
ments in dynamic surface activity observed with the peptoid
1 formulation are similar to those observed with a nonacy-
lated, synthetic, and peptide-based SP-C mimic (15).
Compression-expansion loops for films containing alky-
lated mimics showed greater improvement in dynamic
surface-active properties relative to those for peptoid 1.
Adding one or two alkyl chains to the peptoid similarly
reduced gmin to <1 mN/m, but the gmax-values for the pep-
toid 2 and 3 formulations were reduced to 45 mN/m (versus
51 mN/m), indicating faster respreading upon film expan-
sion (Fig. 1 A and Table 2). The amount of compression
to reach 20 mN/m also decreased to 25% and 23% for pep-
toids 2 and 3, respectively. The addition of at least one alkyl
chain appeared to cause a favorable interaction with the
lipids, engendering a reduction in surface film compress-
ibility as well as an improved interfacial surfactant material
retainment and replenishment upon expansion.LWSB studies
To characterize the influence of the peptoids on monolayer
phase behavior and lipid respreading, we obtained LWSBin 10 min
% Compressionygmin* gmax gmin*
12.25 1.8 63.05 4.0 12.15 2.1 45.15 4.0
< 1 35.45 2.0 < 1 8.05 2.4
< 1 51.05 1.6 < 1 30.55 2.2
< 1 44.45 2.4 < 1 25.15 3.2
< 1 44.85 3.2 < 1 22.95 2.5
ignificantly different (p< 0.05) from each other except for LipidsþMimic
mimic formulations were similar to each other and different from Lipids.
prised of lipids without any added SP-C analog.
< 20 mN/m.
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FIGURE 1 Dynamic PBS results as g versus relative surface area
(surface area/maximum surface area) at 20 cycles/min for 5 min. (A) The
bulk surfactant concentration was 1 mg/mL lipids (DPPC/POPG/PA,
68:22:9 (wt)) at 37C. First compression surface pressure (P)-area (A)
LWSB isotherms for the formulations were collected on a buffered
subphase at 37C. (B) LWSB molecular areas include all surfactant species,
lipid plus SP-C/peptoid.
1080 Brown et al.P-A isotherms at both 25C and 37C for three successive
compression-expansion cycles. Representative first com-
pression isotherms are shown for lipids alone, with porcine
SP-C, and with mimics at 37C (Fig. 1 B). We determined
the relative respreading by comparing the ratio of liftoff
A’s (defined as the A at which P first increases) as well as
at 30 mN/m between the first and third compressions
(Table 3). Results obtained at 25C were comparable
(Fig. S4 and Table S2).
The lipid isotherm lifted off at an A of 98 A˚2/molecule
(Fig. 1 B) with a shallow slope up to 10 mN/m. As the
film was compressed from 10 to 44 mN/m, the isotherm’s
slope increased, indicating less film compressibility. FurtherBiophysical Journal 101(5) 1076–1085lipid film compression led to a kink, or structural transition
to a metastable state, at 47 mN/m (29). The film reached
a high P of 72 mN/m (near-zero g), or collapse. The pres-
ence of SP-C in the lipids at the interface shifted the liftoff
to a greater A of 102 A˚2/molecule, indicating increased
surface activity and an earlier transition to an LE state. At
lower P, the isotherm resembled that of lipids alone, but
shifted toward higher A. However, further compression
resulted in a dramatic plateau region beginning at 43 mN/m,
likely due to increased structural rearrangement in the
surface layer. The SP-C-containing formulation also
collapsed at 72 mN/m.
Inclusion of the nonalkylated peptoid 1 in the lipids
increased the liftoff A to 104 A˚2/molecule, in similarity to
SP-C (Fig. 1 B and Table 3). The isotherm was nearly iden-
tical to the formulation containing SP-C until, at 42 mN/m,
a less pronounced biomimetic plateau region was observed.
The peptoid 1 formulation also exhibited a high collapse P
of 72 mN/m. Introducing one alkyl chain to the peptoid’s
N-terminus resulted in an isotherm nearly identical to pep-
toid 1, with a liftoff A of 105 A˚2/molecule and a plateau
region starting at 43 mN/m. A second peptoid alkyl chain
increased the liftoff to 110 A˚2/molecule for peptoid 3.
Compression of the peptoid 3 film revealed less compress-
ibility than the other formulations, and a plateau region
that was most similar to the SP-C formulation (Fig. 1 B).
To assess peptoid-enhanced surfactant respreading, we
compared the isotherm A’s at liftoff and 30 mN/m on the
third compression with those of the first compression (Table
3). The third compression isotherms were similar to the first
compression (Fig. S4 and Fig. S5), but each formulation
shifted toward smaller A with successive compressions,
indicating loss of surfactant material to the subphase. Rela-
tive to the lipids, the lipid-SP-C formulation improved the
relative recovery of surfactant material at both the liftoff
A and 30 mN/m (82% and 83% vs. 73% and 79%, respec-
tively; Table 3). Addition of peptoid to the lipids also re-
sulted in improved surfactant respreading at the liftoff A
and at 30 mN/m. However, no significant differences (p >
0.05) were observed among the peptoid mimics.FM film morphology imaging
We obtained greater insight into specific lipid-SP-C mimic
interactions by performing FM of the surface film mor-
phology with respect to P. This technique enables direct
visualization of certain aspects of the a/l interfacial surfac-
tant monolayer, and the impact that added species have on
the formation of surfactant domain structures. Film FM
images at 37C, with 0.5 mol % TR-DPHE added, are
shown in Fig. 2, both below (panels A–E) and above (panels
F–J) the plateau region. TR-DPHE is a fluorescently labeled
PL that is excluded from the more-ordered, liquid
condensed (LC) lipid phase upon close lipid packing during
compression; therefore, dark regions in the FM images
TABLE 3 LWSB compression and percent recovery data
Formulation
First compression Third compression % Recovery*
Liftoff area Area at 30 mN/m Liftoff area Area at 30 mN/m Liftoff 30 mN/m
Lipids 98.35 4.2 48.25 1.7 72.15 4.2 38.25 2.5 73.55 4.9 79.35 6.0
Lipids þ SP-C 102.35 0.7 52.25 0.8 84.35 3.3 43.55 3.2 82.45 3.1 83.25 5.1
Lipids þ peptoid 1 104.05 2.0 51.95 0.6 80.85 3.4 41.65 3.0 77.85 4.4 80.25 6.0
Lipids þ peptoid 2 105.35 2.2 53.85 1.4 82.65 5.1 43.85 2.7 78.95 6.1 81.55 5.4
Lipids þ peptoid 3 109.65 4.9 53.95 1.3 85.95 4.9 45.85 2.4 78.35 2.6 85.05 4.9
Data are the mean 5 SD in A˚2/molecule for areas and % for recoveries.
*Term ‘‘% Recovery’’ refers to the percent molecular area at either liftoff or 30 mN/m on the third compression relative to the molecular area of the cor-
responding feature on the first compression.
Alkylated Peptoid Analogues of SP-C 1081represent the ordered LC phase, and lighter regions corre-
spond to the more fluid liquid expanded (LE) phase.
The pure lipid system displayed nucleation of dark LC
domains at 25 mN/m that grew in size upon further
compression (Fig. 2, A and F). At 35 mN/m, the lipid film
exhibited dark LC domains that ranged from 30 to 170
mm2 in area and occupied 18% of the analyzed film area.
Addition of either SP-C or mimics to the lipids resulted in
similar film morphologies at 35 mN/m (Fig. 2, B–E). The
formulations all displayed coexisting LE and LC domains
that were similar to those of the lipid-only film. The relative
size of the LC domains was the main difference between the
SP-C/mimic-containing formulations and the lipid film,
where the LC domain sizes were reduced to 25–50 mm2.
In addition, the alkylated mimics reduced the LC domains
to a greater extent than did peptoid 1. LC domain fractional
area coverages were all 10–17% and not significantly
different from the lipid film.
Increasing the lipid film P to 50 mN/m resulted in LC
domain coalescence and a larger average size (190 mm2)
that occupied the same 22% area observed at 35 mN/m
(Fig. 2 F). The SP-C and peptoid-enhanced film morphol-
ogies were similar at 50 mN/m, but in contrast to the case
at 35 mN/m, they differed from those of the lipid film.
The SP-C formulation LC domains remained the sameLipids alone                SP-C                   Pe
CA B
71 µm2 53 µm225 µm2
~ 35 mN/m
~ 50 mN/m
HF G
190 µm2 50 µm220 µm2
FIGURE 2 FM micrographs at 37C corresponding to P of 35 mN/m and 50
SP-C (B andG), peptoid 1 (C andH), peptoid 2 (D and I), and peptoid 3 (E and J)size (20 mm2) as observed at 35 mN/m and covered the
same 17% film area. SP-C also induced the formation of
small, bright domains in the LE phase, known as 3D protru-
sions (30). These observations are consistent with previous
SP-C experiments in which it partitioned into the fluid-
like phase of the monolayer, altering the lipid packing and
causing film perturbations (31,32) that are important
SP-C-linked characteristics (26,33,34).
The morphology of the peptoid 1 formulation at 50 mN/m
was similar to that observed at 35 mN/m, with LC domains
of 50 mm2 that occupied the same film area. Peptoid 1 also
resulted in the occurrence of bright structures, but their
abundance was less than that observed for the SP-C formu-
lation. Peptoids 2 and 3 produced similar film morphologies,
with an average LC domain size of 35 mm2 and 47 mm2,
respectively, and 12% film coverage. The film’s 3D protru-
sions were present in greater abundance and more similar to
those of the SP-C film. Therefore, all peptoid-based mimics
strongly interacted with lipids, indicating enhanced surface
activity as P increased.AFM
SP-C modulates the fluid lipid phase in compressed lipid
films by inducing 3D structural transitions, forming aptoid 1               Peptoid 2           Peptoid 3
ED
29 µm2 29 µm2
30 µm
JI
35 µm2 47 µm2
mN/m for DPPC/POPG/PA (68:22:9 (wt)) alone (A and F), with 2 mol %
. Average LC domain (dark area) is indicated at the lower left of each panel.
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1082 Brown et al.surfactant reservoir at higher P (10,26,33). This effect is
particularly enhanced in the presence of the palmitoyl
chains. To investigate the influence of SP-C-like alkylation
in the SP-C constructs in a lipid film, we used AFM to study
the film morphology and topography of peptoid 1 and 3
films at two P points. AFM provides the relative height of
interfacial structures at various compression states, and
offers direct mechanistic insight into the observed surface-
activity differences between peptoids 1 and 3. Because pep-
toids 2 and 3 showed statistically similar behaviors, only
peptoid 3 was characterized by AFM. This similarity is
both expected and consistent with variations in SP-C palmi-
toylation across different species (i.e., canine SP-C contains
only one palmitoyl chain).
Fig. 3 A shows the AFM images for the lipid film below
and above the plateau region at 30 mN/m and 60 mN/m,
respectively. Below the plateau region, we observed the co-
existence of both LE and LC domains, consistent with the
FM images (Fig. 2 A). At this P, both large (25–35 mm)
and small (4–6 mm) irregularly shaped LC domains were
present in an interconnected fluid LE phase. We also
observed phase boundary holes or defects in condensed
regions, likely resulting from LE phase incorporation (10).
Height differences between the LC and LE phases at
30 mN/m were 0.5–1.0 nm, consistent with expected height
differences between gel and fluid lipid phases (10).
Compression of the lipids to 60 mN/m led to an interfacial
film that was somewhat uniform in height (Fig. 3 A). LCA Lipids alone B  Peptoid 1          
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FIGURE 3 AFM images and height profiles for lipids alone (DPPC/POPG/PA
30 mN/m and 60 mN/m. A detailed AFM image of the square inset area is pre
Biophysical Journal 101(5) 1076–1085domains increased in size and appeared to be pushed
together, with some fluid-like phase remaining. This is
seemingly in contrast to the FM images, where phase coex-
istence was observed up to the surface layer collapse;
however, it is believed that the observed fluid LE-like phase
is actually a metastable state with thickness comparable to
that of the LC phase (35). At higher P, a few protrusions
5–10 nm high were observed in the formerly fluid phase,
consistent with multilayers of excluded material (10).
At 30 mN/m, addition of either peptoid 1 or 3 to the
surfactant resulted in a film with large, multilobed LC
domains similar to those observed for the lipids alone; how-
ever, much smaller and interspersed LC-like structures were
also observed in the LE region (Fig. 3, B and C). Small and
large LC domain heights were consistent and 1 nm greater
than those of the fluid LE region. As the peptoid 1 and 3
films were compressed, the large LC domains increased in
size, whereas the smaller structures fused together, forming
an interconnected LC phase network among the LE region
(data not shown). For peptoid 1, film compression caused
the fusion of the LC framework, with only large LC domains
and no fluid region (Fig. 3 B). The peptoid 1 formulation at
60 mN/m was similar to the lipid-only film, with no appre-
ciable height difference between the regions and a few
bright protrusions 5–7 nm higher than the surrounding
film. Above the plateau region at 60 mN/m, the AFM
surface topography was distinct for the peptoid 3 film rela-
tive to the lipid-only or peptoid 1 films (Fig. 3 C). In contrastC   Peptoid 3
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Alkylated Peptoid Analogues of SP-C 1083to a film more uniformly composed of fused LC-appearing
domains, the multilobed LC domains remained segregated
within a second interfacial phase derived from the fluid
phase. The former LE region was thicker, with large,
5-nm-high protrusions, suggesting multilayers of excluded
material still associated with the a/l interface (10). This
elevated and interconnected network of excluded surfactant
material is consistent with previous studies of SP-C in
highly compressed lipid films, in which SP-C facilitated
reversible protrusions of stacked bilayers to form a surfac-
tant reservoir attached to the film (10,26).DISCUSSION
In this study, we mimicked SP-C palmitoylation in peptoids
by incorporating Nocd at the achiral N-terminus, preserving
both the hydrophobicity and length of the palmitoylated
cysteine residues in SP-C. Although all of the mimics rep-
licated many of the in vitro surface activities of native
SP-C, the greatest biomimicry was obtained upon peptoid
N-terminal alkylation.
Although alkylation increased the helicity of SP-C by
stabilizing the helix, no alteration in peptoid helicity was
observed for the mimics (5). Because peptoid helices are
derived from steric repulsions, the helix is confined to the
location of the chiral residues and does not change upon
alkylation. Therefore, any changes in activity due to alkyl-
ation were independent of secondary structure. Similarly,
despite the increase in hydrophobicity after alkylation, no
change was observed in surfactant adsorption rates at the
concentrations studied. It is likely that the peptoids are
already sufficiently hydrophobic to promote rapid interfa-
cial adsorption of the dispersed surfactant material. In addi-
tion, the alkyl chains are well incorporated into the
dispersed surfactant and probably do not further perturb
the interfacial lipid film or the suspended liposomes, and
thus do not affect the two-step adsorption process (36).
Controlling g as a function of surface area during the
respiration cycle is a critical function of LS. An efficacious
synthetic LS must reduce gmax upon inspiration and attain
near-zero gmin upon exhalation immediately and continu-
ously throughout the respiration cycle. Dynamic PBS loops
revealed that the SP-C mimics reduced the gmax and gmin of
the lipids, as well as the surfactant compressibility, in simi-
larity to SP-C. Introducing either one or two alkyl chains to
the peptoids markedly reduced the gmax during dynamic
cycling, representing a significant improvement in the film
replenishment during surface expansion, which likely
reduced the work of breathing in vivo (28). The alkyl chains
also decreased the film compressibility to g < 20 mN/m.
These improvements led to PBS loops for the peptoid 2
and 3 films that were similar in shape to those for natural
LS, albeit with higher gmax (45 mN/m vs. 35 mN/m for
natural LS). A possible explanation for the improved
dynamic PBS characteristics postalkylation is that the alkylchains act as hydrophobic lipid anchors, creating surface-
associated surfactant reservoirs that both resist compression
and are readily reincorporated upon film expansion,
reducing both film compressibility and gmax (35,37). There-
fore, despite the dominant role of the helical region in many
of the observed surface-active properties, the N-terminal
palmitoyl-like chains also contribute to the surface activity
of SP-C and SP-C-like species.
We evaluated the peptoids’ ability to insert into and
modulate a film, as well as influence surfactant respreading
and monolayer phase behavior, using both quasi-equilib-
rium LWSB and FM. Isotherm improvements were, in
general, modest and dominated by lipid behavior; however,
favorable changes in structural organization and phase
morphologies were observed at higher P-values. Addition
of either SP-C or peptoids to the film increased the liftoff
area, largely due to the relative size of the added species
at the a/l interface. No significant differences were observed
for peptoids 2 and 3, indicating that the alkyl chains were
well incorporated into the monolayer. Further film compres-
sion led to an isotherm structural transition in the presence
of either SP-C or the peptoids, as observed by a kink or
plateau at 42 mN/m. This kink is believed to coincide
with a 2-3D structural transition in the film and the forma-
tion of surface-associated surfactant multilayer structures
that reversibly unfold upon expansion (10,11,38). Plateau
regions for the mimic-containing films were extended
slightly postalkylation, indicating greater structural refine-
ment; however, the effect was not as extensive as that
observed for SP-C. The peptoids also improved the surfac-
tant morphology similarly to SP-C, reducing ordered LC
domain size at allP-values. Above the plateau region, abun-
dant protrusions were observed in the mimic-containing
films that increased upon alkylation and were similar to
SP-C, in agreement with the results of the LWSB spreading
and PBS cycling experiments.
AFM was used to further probe for a mechanistic expla-
nation of the observed differences in surface activities
between peptoids 1 and 3, which differ only by alkylation.
From the AFM images at lowP, we observed that both pep-
toids 1 and 3 altered the surfactant surface morphology.
Both peptoid-containing formulations had large, multilobed
LC domains surrounded by a more fluid LE phase, consis-
tent with FM images. Numerous smaller domains within
the LE phase were also present and protruded from the
surrounding LE phase. However, as P was increased, only
the film containing peptoid 3 caused a thickening of the in-
terconnected (formerly LE) region. This distinct phase was
maintained along with the LC phase at highP-values. These
results are consistent with observations that natural SP-C
and synthetic peptide-based analogs catalyze the formation
of excluded surfactant structures that reversibly unfold upon
expansion, as depicted previously (10,37,39).
The thickening of the fluid-like phase and maintenance of
two segregated phases in the peptoid 3 film offers insightBiophysical Journal 101(5) 1076–1085
1084 Brown et al.into how the presence of the peptoid alkyl chains affects the
surfactant layer during compression, thereby improving
in vitro surface activity. The alkyl chains assist in a mono-
layer-to-multilayer transition that thickens the more fluid-
like phase. During this process, the alkyl chains act as
hydrophobic anchors that keep the peptoid and surrounding
lipid species tightly associated with the compressed surface
layer, maintaining its interfacial presence at low g (12).
These excluded structures reduce the compressibility of
both the fluid phase and the entire film during compression,
permitting a rapid reduction to low g. Upon expansion,
these excluded structures are rapidly reincorporated to the
interfacial layer to facilitate respreading, reducing gmax.
These seemingly antagonistic properties were echoed in
the PBS loops, where peptoid 3 improved dynamic cycling
properties, resulting in a film that reached low g with less
compression and also had a lower gmax.
Therefore, although all of the peptoids were able to repro-
duce many of SP-C’s biophysical activities, the presence of
alkyl chains most increased the extent of biomimicry. The
precise role of the thioester-linked palmitoyl chains in
SP-C is not known; however, their strict conservation among
all species suggests an important role in SP-C and LS
homeostasis. SP-C, even in the absence of palmitoylation,
has been shown to promote the transfer of material from
the a/l interface to the surface-associated bilayer, forming
a surfactant reservoir that is reincorporated upon expansion
or inhalation (34). However, the palmitoyl chains are
required for the formation of multilayered structures upon
compression, and avoid irreversible collapse of the fluid-
like phase by forming a multilayered, surfactant reservoir
(26). Because the palmitoyl chains of SP-C are well-suited
for insertion into and interaction with the membrane struc-
tures of LS films at high P, it is likely that the alkyl chains
are able to link excluded surfactant material to the a/l sur-
face, forming multilayered surfactant structures (40–43).
The presence of the palmitoyl chains would increase the
retention and respreading of excluded material during respi-
ration, reducing film compressibility and lowering the gmax
during dynamic cycling.
Although some of the biophysical techniques (i.e., PBS
absorption and LWSB compression) employed in this study
showed little to modest differences upon N-terminal alkyl-
ation, other characterization techniques (i.e., dynamic PBS
cycling and AFM) revealed greater changes in dynamic sur-
face properties and film morphologies. Therefore, whereas
the findings obtained by one technique might suggest only
a slight improvement in biophysical activity upon acylation;
the results from all of the techniques in combination reveal
the full significance of the SP-C-like palmitoylation. This
constructed representation supports not only each individual
finding but also the broader hypothesis that a palmitoyl-like
addition results in the formation of multilayered surfactant
structures that remain associated with the a/l surface and
significantly improve biomimicry over the nonacylatedBiophysical Journal 101(5) 1076–1085mimic. This effect is also consistent with previous experi-
mental work that compared acylated and nonacylated
SP-C peptides (41).
Taken together, our results show that peptoid-based
mimics of SP-C are able to exhibit biophysical activities
similar to those of SP-C when combined in a lipid film,
and that the extent of the biomimicry is improved by the
addition of at least one alkyl chain moiety to the N-terminus.
These novel (to our knowledge) species replicate SP-C’s key
molecular and structural motifs, but their side-chain chem-
istry and unique backbone structure reduce many of the
difficulties associated with handling native SP-C. With their
improved stability, favorable production potential, and
reduced risk of pathogenic contamination, peptoid-based
surfactant replacement therapies have the potential to
improve the treatment of infant respiratory distress syn-
drome as well as other, more prevalent respiratory-related
disorders, particularly when greater quantities of surface-
active material are warranted, such as in the case of acute
respiratory distress syndrome.SUPPORTING MATERIAL
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